Innate Pharma SA announces its turnover for the third quarter of 2009 and updates on its cash situation

  • Turnover for the first nine months of 2009 amounted to 2.8 million euros
  • As at September 30, 2009, cash, cash equivalents and current financial instruments amounted 30.5 million euros
     
PR in english 40.5 KB
CP en français 41.63 KB